Physician profile
Joy L Johnson
NPI 1184616120
$1,962.93
in general payments reported to CMS, 2019-2025
20 companies · $78.84 in 2025
The $78.84 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,540 · 2020: $297 · 2022: $15.63 · 2024: $30.75 · 2025: $78.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $109.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $286.35 | 2019-2022 | |
| Lilly USA, LLC | $211.65 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $188.03 | 2019-2020 | |
| Glaxosmithkline, LLC. | $180.60 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $173.37 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $141.80 | 2019 | |
| Astellas Pharma US INC | $104.01 | 2019-2020 | |
| Amgen INC. | $97.38 | 2019-2020 | |
| Abbvie INC. | $92.08 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $81.96 | 2019 | |
| Sanofi-Aventis U.S. LLC | $73.48 | 2019-2020 | |
| Sanofi Pasteur INC. | $66.62 | 2019-2025 | |
| Novo Nordisk INC | $56.39 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.33 | 2019 | |
| Genentech USA, INC. | $45.63 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $30.64 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Averitas Pharma INC. | $29.72 | 2025 | Qutenza |
| Sunovion Pharmaceuticals INC. | $25.80 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $14.45 | 2020 | |
| Amarin Pharma, INC. | $13.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joy Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.